Literature DB >> 8195214

A phospholipase A2 inhibitor from the plasma of the South American rattlesnake (Crotalus durissus terrificus). Protein structure, genomic structure, and mechanism of action.

C L Fortes-Dias1, Y Lin, J Ewell, C R Diniz, T Y Liu.   

Abstract

The lethal toxicity of the South American rattlesnake (Crotalus durissus terrificus) venom can be attributed mainly to the presence of a pre-synaptic neurotoxin, crotoxin, with phospholipase A2 activity. Crotoxin is a heterodimer of an acidic protein (CA) and a basic phospholipase A2 (CB). An anti-toxic protein of subunit molecular mass 23.6 kDa that neutralizes both lethal and PLA2 activity of crotalid venom and crotoxin has been previously purified from the plasma of this snake (Fortes-Dias, C., Fonseca, B. C. B., Kochva, E., and Diniz, C. R. (1991) Toxicon 29, 997-1008). The protein has been named CNF for Crotalus neutralizing factor. In the present study, we have shown that CNF exists as an oligomeric aggregate of (CNF)n, where n = 6-8, and when it interacts with crotoxin, it replaces the acidic protein CA of crotoxin to form a stable near stoichiometric complex of CNF.CB. The CNF.CB complex no longer exhibits PLA2 activity and is inert in vivo. Thus, the exchange reaction between CA.CB of crotoxin and CNF to form CNF.CB and free CA is reminiscent of the interaction of crotoxin with its target receptor at the neuromuscular transmission site in the presynaptic cells. A cDNA encoding CNF has been isolated from a liver cDNA library using an appropriate nucleotide probe. The nucleotide sequence codes for a 19-residue signal peptide, followed by a 181-residue protein of which 16 are half-cystines. Calculated molecular mass is 20.06 kDa, and there is a putative N-linked carbohydrate site at Asn157.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Purification and inhibitory profile of phospholipase A2 inhibitors from Australian elapid sera.

Authors:  P G Hains; K W Broady
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Purification and characterization of three distinct types of phospholipase A2 inhibitors from the blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus.

Authors:  N Ohkura; H Okuhara; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper.

Authors:  S Lizano; B Lomonte; J W Fox; J M Gutiérrez
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Purification, characterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata.

Authors:  K Okumura; K Masui; S Inoue; K Ikeda; K Hayashi
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

5.  Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties.

Authors:  S Lizano; Y Angulo; B Lomonte; J W Fox; G Lambeau; M Lazdunski; J M Gutiérrez
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

6.  Proteomic analysis reveals rattlesnake venom modulation of proteins associated with cardiac tissue damage in mouse hearts.

Authors:  W S Santos; Fabio Montoni; R A S Eichler; Stephanie Santos Suehiro Arcos; Diana Zukas Andreotti; Carolina Yukiko Kisaki; Kimberly Borges Evangelista; Hamida Macêdo Calacina; Ismael Feitosa Lima; Magna Aparecida Maltauro Soares; Eric Conrad Kyle Gren; Valdemir Melechco Carvalho; Emer Suavinho Ferro; Milton Yutaka Nishiyama-Jr; Zhibin Chen; Leo Kei Iwai
Journal:  J Proteomics       Date:  2022-02-17       Impact factor: 3.855

7.  Identification of the B subtype of gamma-phospholipase A2 inhibitor from Protobothrops flavoviridis serum and molecular evolution of snake serum phospholipase A2 inhibitors.

Authors:  Shuhei So; Takahito Chijiwa; Naoki Ikeda; Ikuo Nobuhisa; Naoko Oda-Ueda; Shosaku Hattori; Motonori Ohno
Journal:  J Mol Evol       Date:  2008-03-04       Impact factor: 2.395

Review 8.  Endogenous phospholipase A2 inhibitors in snakes: a brief overview.

Authors:  Patrícia Cota Campos; Lutiana Amaral de Melo; Gabriel Latorre Fortes Dias; Consuelo Latorre Fortes-Dias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21

9.  A snake venom group IIA PLA2 with immunomodulatory activity induces formation of lipid droplets containing 15-d-PGJ2 in macrophages.

Authors:  Karina Cristina Giannotti; Elbio Leiguez; Ana Eduarda Zulim de Carvalho; Neide Galvão Nascimento; Márcio Hideki Matsubara; Consuelo Latorre Fortes-Dias; Vanessa Moreira; Catarina Teixeira
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

10.  Proteomic Analysis of the Ontogenetic Variability in Plasma Composition of Juvenile and Adult Bothrops jararaca Snakes.

Authors:  Karen de Morais-Zani; Kathleen Fernandes Grego; Aparecida Sadae Tanaka; Anita Mitico Tanaka-Azevedo
Journal:  Int J Proteomics       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.